As She Rises brings together local poets and activists from throughout North America to depict the effects of climate change on their home and their people. Each episode carries the listener to a new place through a collection of voices, local recordings and soundscapes. Stories span from the Louisiana Bayou, to the tundras of Alaska to the drying bed of the Colorado River. Centering the voices of native women and women of color, As She Rises personalizes the elusive magnitude of climate cha ...
…
continue reading
コンテンツは Dialogika Podcast によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Dialogika Podcast またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作権で保護された作品をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!
Player FMアプリでオフラインにしPlayer FMう!
Episode 92: The Landscape of COVID-19 Testing
Manage episode 263019219 series 1175366
コンテンツは Dialogika Podcast によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Dialogika Podcast またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作権で保護された作品をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
In this episode, we talk to Levana Sani, co-founder and CEO of Nalagenetics, a meditech company based in Indonesia and Singapore that focuses on genetic testing for drug responses, but has now partially shifted focus to helping set up labs for COVID-19 testing. We dive into the basics of genetic testing, in particular human genotyping, which is what Nalagenetics as a company does in order to help doctors develop personalized medicine for their patients, tailored to their specific genetic profile. We talk to Levi about how her company has pivoted from genetic testing to COVID-19 testing, in particular qPCR (quantitative polymerase chain reaction) testing and comparing this particular method to the more widely known rapid testing method, which has had its critics. We also discuss how Nalagenetics have helped private companies — specifically huge corporations that employ thousands of people — test their workforce and keep their community safe, which goes into the conversation about private and public sector responses to COVID-19 and the democratization of testing. We discuss the ethics behind testing when there are limited test kits and how we can ensure the accessibility of testing to those who really need it.
…
continue reading
101 つのエピソード
Manage episode 263019219 series 1175366
コンテンツは Dialogika Podcast によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Dialogika Podcast またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作権で保護された作品をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal。
In this episode, we talk to Levana Sani, co-founder and CEO of Nalagenetics, a meditech company based in Indonesia and Singapore that focuses on genetic testing for drug responses, but has now partially shifted focus to helping set up labs for COVID-19 testing. We dive into the basics of genetic testing, in particular human genotyping, which is what Nalagenetics as a company does in order to help doctors develop personalized medicine for their patients, tailored to their specific genetic profile. We talk to Levi about how her company has pivoted from genetic testing to COVID-19 testing, in particular qPCR (quantitative polymerase chain reaction) testing and comparing this particular method to the more widely known rapid testing method, which has had its critics. We also discuss how Nalagenetics have helped private companies — specifically huge corporations that employ thousands of people — test their workforce and keep their community safe, which goes into the conversation about private and public sector responses to COVID-19 and the democratization of testing. We discuss the ethics behind testing when there are limited test kits and how we can ensure the accessibility of testing to those who really need it.
…
continue reading
101 つのエピソード
すべてのエピソード
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。